InvestorsHub Logo
Followers 5213
Posts 24013
Boards Moderated 5
Alias Born 09/20/2000

Re: None

Sunday, 09/27/2015 12:50:46 PM

Sunday, September 27, 2015 12:50:46 PM

Post# of 194254
Interesting Consideration with RXMD...

RXMD is one of my favorite stocks for the mid to long terms. I still believe that the debt will be paid off soon. Of course soon is in the eye of the beholder, but let me do the math to guesstimate what I presume ”soon” to be.

The PR below released on September 16, 2015 indicated that RXMD has approximately $585,000 of eligible debt remaining regarding their 3(a)(10) Transaction:
http://finance.yahoo.com/news/progressive-care-issues-3-10-120000313.html

Over the past days since that date of Sep 16 to 25 Sep, 2015, I would say that an average of 2,000,000 shares per trading day have been sold to go towards reducing the debt. That would equate to a total of 16,000,000 shares thus far going towards the debt reduction since Sep 16, 2015. It actually equates to roughly around $10,000 of debt that's being removed per day. I would guess that a no lower than .005 per share would be considered at the rate of those shares being sold since the price was no lower than .005 per share during that time period. That means that...

16,000,000 shares x .005 = $80,000

This means that approximately $80,000 of their 3(a)(10) debt has been removed which would leave a remaining balance of debt to be removed of approximately $505,000 to be eliminated. When you divide that by $10,000 per day as minimum debt bought to be removed, we are looking at another 50.5 trading days as a worst case scenario. Because of the debt not really being a lot compared to most penny stocks given the potential of RXMD, those days could be greatly accelerated which would be indicative from the volume that comes into RXMD as I suspect at some point in time as investors learn how significantly undervalued RXMD is.

I actually see such as a buying opportunity to buy cheap shares here in the .005 per share range (especially lower if it dips), but for some strange reason, the market seems to want to wait until every single penny of that debt is eliminated to pay higher prices. It's strange to me because many of the penny stocks that have been moving are not profitable and are not generating over $12 million in revenues.

Key RXMD Valuation Notes to Consider/Speculate:
1**RXMD generates over $12 million in Revenues
2**Considering a roughly 25% Net Profit Margin, that equates to $3,000,000 Net Income.
3**OS should be around 300,000,000 shares after dilution completes.
4**So… $3,000,000 Net Income ÷ 300,000,000 shares = .01 EPS
5**Below confirms that RXMD is within the Services Sector within the Drug Store Industry:
http://finance.yahoo.com/q/pr?s=RXMD+Profile
6**Below confirms that 17.10 is the PE Ratio for the Drug Store Industry.
http://biz.yahoo.com/p/733conameu.html
7**So… 17.10 PE Ratio x .01 EPS = .171 Per Share Value for RXMD


This means that RXMD should be trading in the .171 per share range if all of the variables above fall in place as I had mentioned above. Even if I am only half right, then RXMD should easily be trading in the .08 to .09 per share range. This is only my opinion based on the Revenues and Net Income I believe that RXMD will achieve and all of the variables I mentioned above in place as such. If for such reason any of the above variables turn out to be better or worse, then simply use the ”Substitution Property” to make the corresponding adjustments accordingly. One should use this post as a framework to get an idea of where RXMD should ”fundamentally” trade if certain variables exist. I truly believe that those who don’t see it now… will see it later.

v/r
Sterling
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RXMD News